Gene · 8553
Papers1,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,588
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phase-specific polarization of peripheral helper T cells influences immunopathology and viral control in HBV infection. | Hepatol Int | 2026 | 41984399 | PubTator, text mining | PubMed |
| KLF2 overrides the resident memory CD8 T cell differentiation program, in opposition to KLF3. | Proc Natl Acad Sci U S A | 2026 | 41871244 | PubTator, text mining | PubMed |
| Genetic variations interact with polybrominated diphenyl ether exposure to alter lipid homeostasis. | Nat Commun | 2026 | 41786719 | PubTator, text mining | PubMed |
| Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies. | Signal Transduct Target Ther | 2026 | 41786685 | PubTator, text mining | PubMed |
| RNA-Seq analysis reveals regulatory networks driven by EpCAM overexpression in esophageal adenocarcinoma cells. | PeerJ | 2026 | 41769390 | PubTator, text mining | PubMed |
| Autoimmune Ocular Surface Disorders: From Molecular Immunopathogenesis to Regenerative and Surgical Therapeutics. | Cells | 2026 | 41744821 | PubTator, text mining | PubMed |
| Hypoxia Promotes an Adrenergic to Mesenchymal Transcriptional Program Transition in Neuroblastoma. | Clin Transl Sci | 2026 | 41724733 | PubTator, text mining | PubMed |
| Neutrophils in the hepatocellular carcinoma microenvironment: orchestrators of progression and immunity. | Front Immunol | 2026 | 41710884 | PubTator, text mining | PubMed |
| Time-Dependent Glucocorticoid-Induced Transcriptomic Changes in Human Trabecular Meshwork and Schlemm's Canal Cells. | Invest Ophthalmol Vis Sci | 2026 | 41636427 | PubTator, text mining | PubMed |
| BHLHE40 Is a Transcriptional Regulatory Target of NFE2L3 in Triple-Negative Breast Cancer. | Oncol Res | 2026 | 41613788 | PubTator, text mining | PubMed |
| Comprehensive tumour-immune profiling reveals TREM2+ tumour-associated macrophages facilitating lymph node metastasis in head and neck squamous cell carcinoma. | Clin Transl Med | 2026 | 41612852 | PubTator, text mining | PubMed |
| Investigating the Multiple Regulatory Mechanisms and Therapeutic Targets of PHLDA1 in Neurological Diseases. | Curr Neuropharmacol | 2026 | 41572777 | PubTator, text mining | PubMed |
| Single-Cell Profiling Across Immune Tissues and Organs Reveals Immunosenescence Signatures in Male Rhesus Monkeys. | Adv Sci (Weinh) | 2026 | 41556329 | PubTator, text mining | PubMed |
| BHLHE40 Expression in Synovial CD4+ T Cells of Rheumatoid Arthritis Patients. | Int J Rheum Dis | 2026 | 41552873 | PubTator, text mining | PubMed |
| Single-cell and multi-omic characterization of ex vivo expanded ASTRLs from stable kidney transplant recipients reveals a regulatory T cell phenotype. | Sci Rep | 2026 | 41535376 | PubTator, text mining | PubMed |
| Tramadol induced hypoxia signaling and paraptosis-like cell death in breast cancer cells via HIF-1α and ATF4 dependent pathways. | Redox Rep | 2026 | 41526224 | PubTator, text mining | PubMed |
| BRRIAR lncRNA alters breast cancer risk by modulating interferon signaling in cis and in trans. | Mol Cancer | 2026 | 41501810 | PubTator, text mining | PubMed |
| Correction: REV-ERB regulates RORγt+ regulatory T cell specification and function through the Bhlhe40-c-Maf axis. | J Exp Med | 2026 | 41411624 | PubTator, text mining | PubMed |
| REV-ERB regulates RORγt+ regulatory T cell specification and function through the Bhlhe40-c-Maf axis. | J Exp Med | 2026 | 41359309 | PubTator, text mining | PubMed |
| Identification of BHLHE40-expressing T cells in giant cell arteritis amplified by interleukin-1. | Immunol Med | 2026 | 41340409 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8553/papers?page=2